Literature DB >> 16061802

Contribution of T cell receptor affinity to overall avidity for virus-specific CD8+ T cell responses.

Katherine Kedzierska1, Nicole L La Gruta, Miles P Davenport, Stephen J Turner, Peter C Doherty.   

Abstract

Prior analysis has characterized the clonal characteristics of effector CD8(+) T cells specific for the prominent influenza A virus nucleoprotein (NP) and acid polymerase (PA) peptides presented by H2D(b). Using a single-cell approach and determination of CDR3beta profiles, a limited, predominantly "public" repertoire was found for CD8(+)D(b)NP(366)(+)Vbeta8.3+ cells, whereas diverse and "private" T cell antigen receptor (TCR)beta clonotypes were typical of the CD8(+)D(b)PA(224)(+)Vbeta7+ response. This single-cell approach has now been used to relate the contributions of particular clonotypes (or affinities) to high-avidity TCRs, as defined by binding under conditions of limiting tetramer availability. At least by the measure of CDR3beta usage, no difference could be found between total and high-avidity populations in the spectrum of TCR-pMHC affinities throughout the limited, and relatively public, CD8(+)D(b)NP(366)(+)Vbeta8.3+ populations. Conversely, the more even (by clone size), diverse, and private CD8(+)D(b)PA(224)(+)Vbeta7+ response was characterized by the clear partitioning of the largest T cell clones in the high-avidity compartment. These results suggest that the relatively constrained CD8(+)D(b)NP(366)(+)Vbeta8.3+ set utilizes a relatively narrow range of affinities, whereas the broader CD8(+)D(b)PA(224)(+)Vbeta7+ response is induced at a range of TCR-pMHC affinities. Thus, whereas TCR sequence (or affinity) appears to contribute substantially to the avidity profile of diverse virus-specific CD8+ populations, other mechanisms may be prominent where the TCR spectrum is more limited.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16061802      PMCID: PMC1183580          DOI: 10.1073/pnas.0504851102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Role of CD8beta domains in CD8 coreceptor function: importance for MHC I binding, signaling, and positive selection of CD8+ T cells in the thymus.

Authors:  R Bosselut; S Kubo; T Guinter; J L Kopacz; J D Altman; L Feigenbaum; A Singer
Journal:  Immunity       Date:  2000-04       Impact factor: 31.745

2.  The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides.

Authors:  A R Townsend; J Rothbard; F M Gotch; G Bahadur; D Wraith; A J McMichael
Journal:  Cell       Date:  1986-03-28       Impact factor: 41.582

3.  Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy.

Authors:  M A Alexander-Miller; G R Leggatt; J A Berzofsky
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

4.  Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes.

Authors:  F Crawford; H Kozono; J White; P Marrack; J Kappler
Journal:  Immunity       Date:  1998-06       Impact factor: 31.745

5.  Future influenza vaccines and the use of genetic recombinants.

Authors:  E D Kilbourne
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

6.  The sizes of the CDR3 hypervariable regions of the murine T-cell receptor beta chains vary as a function of the recombined germ-line segments.

Authors:  C Pannetier; M Cochet; S Darche; A Casrouge; M Zöller; P Kourilsky
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

7.  Cellular events in the lymph node and lung of mice with influenza. Consequences of depleting CD4+ T cells.

Authors:  W Allan; Z Tabi; A Cleary; P C Doherty
Journal:  J Immunol       Date:  1990-05-15       Impact factor: 5.422

8.  The three-dimensional structure of H-2Db at 2.4 A resolution: implications for antigen-determinant selection.

Authors:  A C Young; W Zhang; J C Sacchettini; S G Nathenson
Journal:  Cell       Date:  1994-01-14       Impact factor: 41.582

9.  How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model.

Authors:  M G von Herrath; J Dockter; M B Oldstone
Journal:  Immunity       Date:  1994-06       Impact factor: 31.745

10.  Protective immunity does not correlate with the hierarchy of virus-specific cytotoxic T cell responses to naturally processed peptides.

Authors:  A Gallimore; T Dumrese; H Hengartner; R M Zinkernagel; H G Rammensee
Journal:  J Exp Med       Date:  1998-05-18       Impact factor: 14.307

View more
  27 in total

1.  Antiretroviral therapy reduces the magnitude and T cell receptor repertoire diversity of HIV-specific T cell responses without changing T cell clonotype dominance.

Authors:  Joseph A Conrad; Ramesh K Ramalingam; Coley B Duncan; Rita M Smith; Jie Wei; Louise Barnett; Brenna C Simons; Shelly L Lorey; Spyros A Kalams
Journal:  J Virol       Date:  2012-01-18       Impact factor: 5.103

2.  Early establishment of diverse T cell receptor profiles for influenza-specific CD8(+)CD62L(hi) memory T cells.

Authors:  Katherine Kedzierska; Vanessa Venturi; Kenneth Field; Miles P Davenport; Stephen J Turner; Peter C Doherty
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-05       Impact factor: 11.205

Review 3.  Tracking phenotypically and functionally distinct T cell subsets via T cell repertoire diversity.

Authors:  Katherine Kedzierska; Nicole L La Gruta; John Stambas; Stephen J Turner; Peter C Doherty
Journal:  Mol Immunol       Date:  2007-08-24       Impact factor: 4.407

4.  Influenza-specific lung-resident memory T cells are proliferative and polyfunctional and maintain diverse TCR profiles.

Authors:  Angela Pizzolla; Thi Ho Nguyen; Sneha Sant; Jade Jaffar; Tom Loudovaris; Stuart I Mannering; Paul G Thomas; Glen P Westall; Katherine Kedzierska; Linda M Wakim
Journal:  J Clin Invest       Date:  2018-01-08       Impact factor: 14.808

5.  Dominant clonotypes within HIV-specific T cell responses are programmed death-1high and CD127low and display reduced variant cross-reactivity.

Authors:  Joseph A Conrad; Ramesh K Ramalingam; Rita M Smith; Louise Barnett; Shelly L Lorey; Jie Wei; Brenna C Simons; Shanmugalakshmi Sadagopal; Dirk Meyer-Olson; Spyros A Kalams
Journal:  J Immunol       Date:  2011-05-11       Impact factor: 5.422

6.  Comparative studies of infectivity, immunogenicity and cross-protective efficacy of live attenuated influenza vaccines containing nucleoprotein from cold-adapted or wild-type influenza virus in a mouse model.

Authors:  Irina Isakova-Sivak; Daniil Korenkov; Tatiana Smolonogina; Tatiana Tretiak; Svetlana Donina; Andrey Rekstin; Anatoly Naykhin; Svetlana Shcherbik; Nicholas Pearce; Li-Mei Chen; Tatiana Bousse; Larisa Rudenko
Journal:  Virology       Date:  2016-11-06       Impact factor: 3.616

7.  Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza.

Authors:  Victor C Huber; Raelene M McKeon; Martha N Brackin; Laura A Miller; Rachael Keating; Scott A Brown; Natalia Makarova; Daniel R Perez; Gene H Macdonald; Jonathan A McCullers
Journal:  Clin Vaccine Immunol       Date:  2006-09

Review 8.  CD8 T cell responses to influenza virus infection in aged mice.

Authors:  Jiu Jiang; Erin M Fisher; Donna M Murasko
Journal:  Ageing Res Rev       Date:  2011-02-15       Impact factor: 10.895

9.  A novel method for analysis of human T cell repertoires by real-time PCR.

Authors:  Peter J Wettstein; Nancy D Borson; Neil E Kay
Journal:  J Immunol Methods       Date:  2014-06-28       Impact factor: 2.303

10.  Relationship between CD8-dependent antigen recognition, T cell functional avidity, and tumor cell recognition.

Authors:  Tamson V Moore; Gretchen E Lyons; Natasha Brasic; Jeffrey J Roszkowski; Simon Voelkl; Andreas Mackensen; W Martin Kast; I Caroline Le Poole; Michael I Nishimura
Journal:  Cancer Immunol Immunother       Date:  2008-10-03       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.